期刊文献+

HIF-1α及PI3K/Akt信号通路在中耳胆脂瘤中的表达及意义 被引量:2

Expression and significance of PI3K/Akt/HIF-1αpathway in middle ear cholesteatoma
下载PDF
导出
摘要 目的探讨PI3K/Akt在通路在中耳胆脂瘤中的表达及意义。方法通过免疫组化检测胆脂瘤组织中HIF-1α的表达;Spearman相关性分析HIF-1α与胆脂瘤患者骨质破坏程度的相关性。同时培养胆脂瘤原代细胞(MEC),检测缺氧条件下MEC增殖速度的改变及给予PI3K/Akt通路抑制剂对MEC增殖的影响;Western blot检测PI3K/Akt抑制剂对HIF-1α及PI3K/Akt通路关键蛋白磷酸化的影响。结果胆脂瘤中HIF-1α的表达为(++)及(+++)细胞比例明显高于对照组(P<0.05);胆脂瘤骨质破坏程度与HIF-1α的表达呈正相关(P=0.012)(r值=16.286);缺氧条件促进MCE增殖,LY294022在缺氧条件下抑制MEC的增殖;缺氧条件下HIF-1α、p-PI3K蛋白及p-Akt蛋白308、492位点都出现不同程度的升高。而给予LY294002干预后,p-PI3K及p-Akt-308、492位点及HIF-1α被明显抑制。结论PI3K/Akt信号通路在缺氧条件下调节胆脂瘤细胞的增殖,对HIF-1α具有正向调节作用;通过抑制PI3K/Akt信号通路可以减缓胆脂瘤的增殖速度,其可能机制是PI3K/Akt通路通过下调HIF-1α的表达而实现的。 Objective To investigate the expression and significance of PI3K/Akt/HIF-1αpathway in middle ear cholesteatoma.Methods The expression levels of HIF-1αin cholesteatoma tissues were detected by immunohistochemistry.Spearman correlation was used to analyze the correlation between HIF-1αand bone destruction in patients with cholesteatoma.At the same time,cultured cholesteatoma primary cells(MEC)were used to detect the change of MEC proliferation rate under hypoxia and the effects of PI3K/Akt pathway inhibitor on MEC proliferation,Moreover the effects of PI3K/Akt inhibitors on the phosphorylation of key proteins in HIF-1αand PI3K/Akt pathway were detected by Western Blot.Results The expression levels of HIF-1αin cholesteatoma tissues were(++)and(+++)of cell proportion,which were significantly higher than those in control group(P<0.05).The degree of bone destruction in cholesteatoma was positively correlated with the expression of HIF-1α(P<0.05),and hypoxia condition promoted MCE proliferation,LY294022 inhibited MEC expression under hypoxia.Moreover hypoxia-inducible factors including HIF-1α,p-PI3K protein and p-Akt protein in 308,492 locus had increasing at different extents.After LY294002 intervention,p-PI3K and p-Akt-in 308,492 locus and HIF-1αwere significantly inhibited.Conclusion The PI3K/Akt signaling pathway can regulate the proliferation of cholesteatoma cells under hypoxic conditions,which has a positive regulatory effect on HIF-1α.By inhibiting the PI3K/Akt signaling pathway,the proliferation rate of cholesteatoma is decreased,and its action mechanism may be that the PI3K/Akt pathway is achieved by down-regulating the expression of HIF-1α.
作者 马佐鹏 李全成 MA Zuopeng;LI Quancheng(Department of Otorhinolaryngology, Qinghai Red Cross Hospital,Qinghai, Xining 810000,China;不详)
出处 《河北医药》 CAS 2020年第15期2259-2263,共5页 Hebei Medical Journal
基金 青海省医药卫生科技计划项目(编号:2018KY373)。
关键词 PI3K AKT 缺氧诱导因子-1Α 胆脂瘤 分子机制 PI3K Akt HIF-1α cholesteatoma molecular mechanism
  • 相关文献

参考文献2

二级参考文献26

  • 1DJURHUUS B D, SKYTTHE A, CHRISTENSEN K, et al. Cholesteatoma in Danish children-A national study of changes in the incidence rate over 34 years[J]. Int J Pediatr Otorhinolaryngol, 2015,79 : 127-- 130.
  • 2DORNELLES C, MEURER L, SELAIMEN DA COSTA S, et al. Histologic description of acquired eholesteatomas: comparison between children and a- dults[J]. Braz J Otorhinolaryngol, 2006, 72:641 -- 648.
  • 3KUO C L. Etiopathogenesis of acquired cholesteato- ma:prominent theories and recent advances in biomo- lecular research[J] . Laryngoscope, 2015,125 : 234-- 240.
  • 4JACKLER R K, SANTA MARIA P L, VARSAK Y K, et al. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction[J]. Laryngoscope, 2015,125 Suppl 4:S1--S14.
  • 5LOUW L. Acquired cholesteatoma: summary of the cascade of molecular events[J]. J Laryngol Otol, 2013,127..542--549.
  • 6SZCZEPANSKI M J, LUCZAK M, OLSZEWSKA E,et al. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis [J]. J Mol Med (Berl), 2015,93305--314.
  • 7CHI Z, WANG Z, LIANG Q, et al. Induction of cy- tokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes [J]. Mol Cell Biochem, 2015,400(I-- 2) : 189--200.
  • 8VISSE R, NAGASE H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[J]. Circ Res, 2003,92: 827--839.
  • 9JUH,SZ A, SZIKLAI I, R.KOSY Z, et aL Elevat- ed level of tenascin and matrix metalloproteinase 9correlates with the bone destruction capacity of chol- esteatomas[J]. Oto] Neuroto], 2009,30 : 559-- 565.
  • 10REZENDE C E, SOUTO R P, RAPOPORT P B,et al. Cholesteatoma gene expression of matrixmetallo- proteinases and their inhibitors by RT-PCR[J]. Braz J Otorhinolaryngol, 2012,78 : 116-- 121.

共引文献21

同被引文献27

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部